Inflammation

, Volume 39, Issue 5, pp 1660–1669 | Cite as

Astragaloside IV Inhibits the Inflammatory Injury of Chicken Type II Pneumocytes Induced by Avian Pathogenic Escherichia coli

  • Li-Yan Zhang
  • Peng-Fei Yi
  • Xun Guo
  • Shuai-Cheng Wu
  • Yun-Xing Fu
  • Cui Zhang
  • Ben-Dong Fu
  • Hai-Qing Shen
  • Xu-Bin Wei
ORIGINAL ARTICLE
First Online:
  • 249 Downloads

Abstract

Avian pathogenic Escherichia coli (APEC) induces septicemia in chickens by invading type II pneumocytes after breaching the blood–air barrier. Type II pneumocytes play an important role in maintaining the function of the blood–air barrier. Astragaloside IV has been shown in previous studies to have an anti-inflammatory effect. To explore whether astragaloside IV can inhibit APEC-induced injury in chicken type II pneumocytes, cells were infected with APEC-O78. The results showed that astragaloside IV significantly reduced cell damage in chicken type II pneumocytes induced by APEC-O78 by downregulating the production of TNF-α and IL-1β, upregulating the secretion of IL-4 and IL-10, suppressing the mRNA levels of TLR-4, TLR-5, ERK, and p38 of chicken type II pneumocytes as well as inhibiting bacterial adhesion and F-actin cytoskeleton polymerization. These results suggest that astragaloside IV may be useful in novel pharmaco-therapeutic approaches to the treatment of chicken colibacillosis.

KEY WORDS

chicken type II pneumocyte avian pathogenic Escherichia coli injury astragaloside IV 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

We thank Matthew Engel of Cornell University for the very careful editing of the manuscript. This work was supported by the National Natural Science Foundation of China (No. 31372470) and China Postdoctoral Science Special Foundation (No. 2014T70297).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Supplementary material

10753_2016_400_MOESM1_ESM.ppt (2.4 mb)
ESM 1 (PPT 2503 kb)

References

  1. 1.
    Alexopoulou, L., A.C. Holt, R. Medzhitov, and R.A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857): 732–738. doi: 10.1038/35099560.CrossRefPubMedGoogle Scholar
  2. 2.
    Arne, P., D. Marc, A. Bree, C. Schouler, and M. Dho-Moulin. 2000. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion. Avian Diseases 44(2): 343–355.CrossRefPubMedGoogle Scholar
  3. 3.
    Banan, A., Y. Zhang, J. Losurdo, and A. Keshavarzian. 2000. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46(6): 830–837.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Blum, M.S., E. Toninelli, J.M. Anderson, M.S. Balda, J. Zhou, L. O’Donnell, R. Pardi, and J.R. Bender. 1997. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. American Journal of Physiology 273(1 Pt 2): H286–294.PubMedGoogle Scholar
  5. 5.
    Chanteloup, N.K., G. Porcheron, B. Delaleu, P. Germon, C. Schouler, M. Moulin-Schouleur, and P. Gilot. 2011. The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. Veterinary Microbiology 147(3-4): 435–439. doi: 10.1016/j.vetmic.2010.07.013.CrossRefPubMedGoogle Scholar
  6. 6.
    Chen, P., Y. Xie, E. Shen, G.G. Li, Y. Yu, C.B. Zhang, Y. Yang, et al. 2011. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-beta1 signaling in coxsackievirus B3-induced cardiomyopathy. European Journal of Pharmacology 658(2-3): 168–174. doi: 10.1016/j.ejphar.2011.02.040.CrossRefPubMedGoogle Scholar
  7. 7.
    Chen, X., L.H. Peng, Y.H. Shan, N. Li, W. Wei, L. Yu, Q.M. Li, W.Q. Liang, and J.Q. Gao. 2013. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. International Journal of Pharmaceutics 447(1-2): 171–181. doi: 10.1016/j.ijpharm.2013.02.054.CrossRefPubMedGoogle Scholar
  8. 8.
    Dho-Moulin, M., and J.M. Fairbrother. 1999. Avian pathogenic Escherichia coli (APEC). Veterinary Research 30(2-3): 299–316.PubMedGoogle Scholar
  9. 9.
    Grutz, G. 2005. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. Journal of Leukocyte Biology 77: 3–15. doi: 10.1189/Jlb.0904484.PubMedGoogle Scholar
  10. 10.
    Guo, X., L.Y. Zhang, S.C. Wu, F. Xia, Y.X. Fu, Y.L. Wu, C.Q. Leng, et al. 2014. Andrographolide interferes quorum sensing to reduce cell damage caused by avian pathogenic Escherichia coli. Veterinary Microbiology 174(3-4): 496–503. doi: 10.1016/j.vetmic.2014.09.021.CrossRefPubMedGoogle Scholar
  11. 11.
    Hayashi, F., K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, D.R. Goodlett, J.K. Eng, S. Akira, D.M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410(6832): 1099–1103. doi: 10.1038/35074106.CrossRefPubMedGoogle Scholar
  12. 12.
    Huber, F., J. Schnauss, S. Ronicke, P. Rauch, K. Muller, C. Futterer, and J. Kas. 2013. Emergent complexity of the cytoskeleton: from single filaments to tissue. Advances in Physics 62(1): 1–112. doi: 10.1080/00018732.2013.771509.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    La Ragione, R.M., W.A. Cooley, and M.J. Woodward. 2000. The role of fimbriae and flagella in the adherence of avian strains of Escherichia coli O78:K80 to tissue culture cells and tracheal and gut explants. Journal of Medical Microbiology 49(4): 327–338.CrossRefPubMedGoogle Scholar
  14. 14.
    Lahouassa, H., E. Moussay, P. Rainard, and C. Riollet. 2007. Differential cytokine and chemokine responses of bovine mammary epithelial cells to Staphylococcus aureus and Escherichia coli. Cytokine 38(1): 12–21. doi: 10.1016/j.cyto.2007.04.006.CrossRefPubMedGoogle Scholar
  15. 15.
    Lin, L.I.N., S.H.E.N. Hong, W.A.N.G. Li-xin, Z.H.O.U. Xiao-bo, W.U. Jing, X.U. Yi, Z.H.A.O. Song, L.I.U. Zeng-wei, G.E. Chao, and L.I.U. Ya-jun. 2011. Effects of astragaloside IV and β-elemene on immunologic function of dendritic cells in rats. Journal of Southeast University (Medical Science Edition) 2: 007.Google Scholar
  16. 16.
    Maina, J.N., and A.S. King. 1982. The thickness of avian blood-gas barrier: qualitative and quantitative observations. Journal of Anatomy 134(Pt 3): 553–562.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Matter, L.B., N.L. Barbieri, M. Nordhoff, C. Ewers, and F. Horn. 2011. Avian pathogenic Escherichia coli MT78 invades chicken fibroblasts. Veterinary Microbiology 148(1): 51–59. doi: 10.1016/j.vetmic.2010.08.006.CrossRefPubMedGoogle Scholar
  18. 18.
    Ren, G.W., X. Zhao, L.Y. Zhang, J.M. Zhang, A. L’Huillier, W.F. Ling, A.I. Roberts, et al. 2010. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. Journal of Immunology 184(5): 2321–2328. doi: 10.4049/jimmunol.0902023.CrossRefGoogle Scholar
  19. 19.
    Rodriguez-Siek, K.E., C.W. Giddings, C. Doetkott, T.J. Johnson, and L.K. Nolan. 2005. Characterizing the APEC pathotype. Veterinary Research 36(2): 241–256. doi: 10.1051/vetres:2004057.CrossRefPubMedGoogle Scholar
  20. 20.
    Satoh, H., G.S. Firestein, P.B. Billings, J.P. Harris, and E.M. Keithley. 2003. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. Journal of the Association for Research in Otolaryngology 4(2): 139–147.CrossRefPubMedGoogle Scholar
  21. 21.
    Schouler, C., B. Schaeffer, A. Bree, A. Mora, G. Dahbi, F. Biet, E. Oswald, J. Mainil, J. Blanco, and M. Moulin-Schouleur. 2012. Diagnostic strategy for identifying avian pathogenic Escherichia coli based on four patterns of virulence genes. Journal of Clinical Microbiology 50(5): 1673–1678. doi: 10.1128/JCM.05057-11.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Seger, Rony, and E.G. Krebs. 1995. The MAPK signaling cascade. The FASEB Journal 9(9): 726–735.PubMedGoogle Scholar
  23. 23.
    Su, C.C., T.L. Chiou, M.H. Chan, and J.G. Lin. 2009. Astragaloside IV increases MMP-2 mRNA and protein expression in human lung cancer A549 cells. Molecular Medicine Reports 2(1): 107–113. doi: 10.3892/mmr_00000070.PubMedGoogle Scholar
  24. 24.
    Takeda, Kiyoshi, Tsuneyasu Kaisho, and Shizuo Akira. 2003. Toll-like receptors. Annual Review of Immunology 21(1): 335–376.CrossRefPubMedGoogle Scholar
  25. 25.
    Wu, J., H. Suzuki, A.A. Akhand, Y.W. Zhou, K. Hossain, and I. Nakashima. 2002. Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells. Cellular Signalling 14(6): 509–515.CrossRefPubMedGoogle Scholar
  26. 26.
    Xing, Z., Y. Ohkawara, M. Jordana, F.L. Graham, and J. Gauldie. 1997. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Therapy 4(2): 140–149. doi: 10.1038/sj.gt.3300371.CrossRefPubMedGoogle Scholar
  27. 27.
    Xu, X.L., H. Ji, S.Y. Gu, Q. Shao, Q.J. Huang, and Y.P. Cheng. 2007. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. European Journal of Pharmacology 568(1-3): 203–212. doi: 10.1016/j.ejphar.2007.04.007.CrossRefPubMedGoogle Scholar
  28. 28.
    Yerushalmi, Z., N.I. Smorodinsky, M.W. Naveh, and E.Z. Ron. 1990. Adherence pili of avian strains of Escherichia coli O78. Infection and Immunity 58(4): 1129–1131.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Yuan, W.L., H.Z. Chen, Y.Z. Yang, X.Y. Yang, Y.S. Lin, P.Y. Jin, and T.S. Zhou. 1990. Effect of Astragalus membranaceus on electric activities of cultured rat beating heart cells infected with coxsackie B-2 virus. Chinese Medical Journal 103(3): 177–182.PubMedGoogle Scholar
  30. 30.
    Yuan, X., S. Sun, S. Wang, and Y. Sun. 2011. Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma. Planta Medica 77(4): 328–333. doi: 10.1055/s-0030-1250408.CrossRefPubMedGoogle Scholar
  31. 31.
    Yun, K.J., J.Y. Kim, J.B. Kim, K.W. Lee, S.Y. Jeong, H.J. Park, H.J. Jung, Y.W. Cho, K. Yun, and K.T. Lee. 2008. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. International Immunopharmacology 8(3): 431–441. doi: 10.1016/j.intimp.2007.11.003.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhang, L.Y., S. Lv, S.C. Wu, X. Guo, F. Xia, X.R. Hu, Z. Song, et al. 2014. Inhibitory effects of alpha-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes. Veterinary Immunology and Immunopathology 159(1-2): 50–57. doi: 10.1016/j.vetimm.2014.02.005.CrossRefPubMedGoogle Scholar
  33. 33.
    Zhang, Y., H. Zhu, C. Huang, X. Cui, Y. Gao, Y. Huang, W. Gong, Y. Zhao, and S. Guo. 2006. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. Journal of Cardiovascular Pharmacology 47(2): 190–195. doi: 10.1097/01.fjc.0000199683.43448.64.CrossRefPubMedGoogle Scholar
  34. 34.
    Zhong, L.M., Y. Zong, L. Sun, J.Z. Guo, W. Zhang, Y. He, R. Song, W.M. Wang, C.J. Xiao, and D. Lu. 2012. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS One 7(2): e32195. doi: 10.1371/journal.pone.0032195.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Li-Yan Zhang
    • 1
  • Peng-Fei Yi
    • 1
  • Xun Guo
    • 1
  • Shuai-Cheng Wu
    • 1
  • Yun-Xing Fu
    • 1
  • Cui Zhang
    • 2
  • Ben-Dong Fu
    • 1
  • Hai-Qing Shen
    • 1
  • Xu-Bin Wei
    • 1
  1. 1.Department of Clinical Veterinary Medicine, College of Veterinary MedicineJilin UniversityChangchunChina
  2. 2.Yunfu Quantity and Metrology Supervision Testing Institute of Guangdong ProvinceYunfuChina

Personalised recommendations